<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T09:12:26Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7286366" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7286366</identifier>
        <datestamp>2020-06-15</datestamp>
        <setSpec>cid</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Clin Infect Dis</journal-id>
              <journal-id journal-id-type="iso-abbrev">Clin. Infect. Dis</journal-id>
              <journal-id journal-id-type="publisher-id">cid</journal-id>
              <journal-title-group>
                <journal-title>Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1058-4838</issn>
              <issn pub-type="epub">1537-6591</issn>
              <publisher>
                <publisher-name>Oxford University Press</publisher-name>
                <publisher-loc>US</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7286366</article-id>
              <article-id pub-id-type="pmcid">PMC7286366</article-id>
              <article-id pub-id-type="pmc-uid">7286366</article-id>
              <article-id pub-id-type="pmid">31359053</article-id>
              <article-id pub-id-type="doi">10.1093/cid/ciz717</article-id>
              <article-id pub-id-type="publisher-id">ciz717</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Articles and Commentaries</subject>
                </subj-group>
                <subj-group subj-group-type="category-taxonomy-collection">
                  <subject>AcademicSubjects/MED00290</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Cost-effectiveness of an Environmental Cleaning Bundle for Reducing Healthcare-associated Infections</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9292-0773</contrib-id>
                  <name>
                    <surname>White</surname>
                    <given-names>Nicole M</given-names>
                  </name>
                  <xref ref-type="aff" rid="AF0001">1</xref>
                  <xref ref-type="aff" rid="AF0002">2</xref>
                  <xref ref-type="corresp" rid="c1"/>
                  <!--<email>nm.white@qut.edu.au</email>-->
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Barnett</surname>
                    <given-names>Adrian G</given-names>
                  </name>
                  <xref ref-type="aff" rid="AF0001">1</xref>
                  <xref ref-type="aff" rid="AF0002">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hall</surname>
                    <given-names>Lisa</given-names>
                  </name>
                  <xref ref-type="aff" rid="AF0002">2</xref>
                  <xref ref-type="aff" rid="AF0003">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mitchell</surname>
                    <given-names>Brett G</given-names>
                  </name>
                  <xref ref-type="aff" rid="AF0004">4</xref>
                  <xref ref-type="aff" rid="AF0005">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Farrington</surname>
                    <given-names>Alison</given-names>
                  </name>
                  <xref ref-type="aff" rid="AF0001">1</xref>
                  <xref ref-type="aff" rid="AF0002">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Halton</surname>
                    <given-names>Kate</given-names>
                  </name>
                  <xref ref-type="aff" rid="AF0002">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Paterson</surname>
                    <given-names>David L</given-names>
                  </name>
                  <xref ref-type="aff" rid="AF0006">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Riley</surname>
                    <given-names>Thomas V</given-names>
                  </name>
                  <xref ref-type="aff" rid="AF0007">7</xref>
                  <xref ref-type="aff" rid="AF0008">8</xref>
                  <xref ref-type="aff" rid="AF0009">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gardner</surname>
                    <given-names>Anne</given-names>
                  </name>
                  <xref ref-type="aff" rid="AF0002">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Page</surname>
                    <given-names>Katie</given-names>
                  </name>
                  <xref ref-type="aff" rid="AF0002">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gericke</surname>
                    <given-names>Christian A</given-names>
                  </name>
                  <xref ref-type="aff" rid="AF0010">10</xref>
                  <xref ref-type="aff" rid="AF0011">11</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Graves</surname>
                    <given-names>Nicholas</given-names>
                  </name>
                  <xref ref-type="aff" rid="AF0001">1</xref>
                  <xref ref-type="aff" rid="AF0002">2</xref>
                </contrib>
              </contrib-group>
              <aff id="AF0001"><label>1</label><institution>Australian Centre for Health Services Innovation, Institute of Health and Biomedical Innovation</institution>, Brisbane, Queensland, Western Australia</aff>
              <aff id="AF0002"><label>2</label><institution>School of Public Healt, New South Wales,h and Social Work, Queensland University of Technology</institution>, Brisbane, Western Australia</aff>
              <aff id="AF0003"><label>3</label><institution>School of Public Health, University of Queensland</institution>, Brisbane, Western Australia</aff>
              <aff id="AF0004"><label>4</label><institution>Discipline of Nursing, Avondale College of Higher Education</institution>, Wahroonga, New South Wales, Western Australia</aff>
              <aff id="AF0005"><label>5</label><institution>School of Nursing and Midwifery, University of Newcastle</institution>, New South Wales, Western Australia</aff>
              <aff id="AF0006"><label>6</label><institution>University of Queensland Centre for Clinical Research, Royal Brisbane and Women’s Hospital</institution>, Crawley, Western Australia</aff>
              <aff id="AF0007"><label>7</label><institution>School of Biomedical Sciences, The University of Western Australia</institution>, Crawley, Western Australia</aff>
              <aff id="AF0008"><label>8</label><institution>School of Medical and Health Sciences, Edith Cowan University</institution>, Joondalup, Western Australia</aff>
              <aff id="AF0009"><label>9</label><institution>School of Veterinary and Life Sciences, Murdoch University</institution>, Western Australia,, Cairns, Queensland, Australia</aff>
              <aff id="AF0010"><label>10</label><institution>School of Clinical Medicine, University of Queensland</institution>, Cairns, Queensland, Brisbane, Australia</aff>
              <aff id="AF0011"><label>11</label><institution>College of Public Health, Medical and Veterinary Sciences, and College of Medicine and Dentistry, James Cook University</institution>, Cairns, Queensland, Australia</aff>
              <author-notes>
                <corresp id="c1">Correspondence: N. M. White, Institute of Health and Biomedical Innovation, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, Queensland, Australia, 4059 (<email>nm.white@qut.edu.au</email>).</corresp>
              </author-notes>
              <pub-date pub-type="ppub">
                <day>15</day>
                <month>6</month>
                <year>2020</year>
              </pub-date>
              <pub-date pub-type="epub" iso-8601-date="2019-07-30">
                <day>30</day>
                <month>7</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>30</day>
                <month>7</month>
                <year>2019</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
              <volume>70</volume>
              <issue>12</issue>
              <fpage>2461</fpage>
              <lpage>2468</lpage>
              <history>
                <date date-type="received">
                  <day>01</day>
                  <month>5</month>
                  <year>2019</year>
                </date>
                <date date-type="accepted">
                  <day>29</day>
                  <month>7</month>
                  <year>2019</year>
                </date>
                <date date-type="corrected-typeset">
                  <day>30</day>
                  <month>8</month>
                  <year>2019</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license license-type="cc-by-nc-nd" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
                  <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
                </license>
              </permissions>
              <self-uri xlink:href="ciz717.pdf"/>
              <abstract>
                <title>Abstract</title>
                <sec id="s0100">
                  <title>Background</title>
                  <p>Healthcare-associated infections (HAIs) remain a significant patient safety issue, with point prevalence estimates being ~5% in high-income countries. In 2016–2017, the Researching Effective Approaches to Cleaning in Hospitals (REACH) study implemented an environmental cleaning bundle targeting communication, staff training, improved cleaning technique, product use, and audit of frequent touch-point cleaning. This study evaluates the cost-effectiveness of the environmental cleaning bundle for reducing the incidence of HAIs.</p>
                </sec>
                <sec id="s0101">
                  <title>Methods</title>
                  <p>A stepped-wedge, cluster-randomized trial was conducted in 11 hospitals recruited from 6 Australian states and territories. Bundle effectiveness was measured by the numbers of <italic>Staphylococcus aureus</italic> bacteremia, <italic>Clostridium difficile</italic> infection, and vancomycin-resistant enterococci infections prevented in the intervention phase based on estimated reductions in the relative risk of infection. Changes to costs were defined as the cost of implementing the bundle minus cost savings from fewer infections. Health benefits gained from fewer infections were measured in quality-adjusted life-years (QALYs). Cost-effectiveness was evaluated using the incremental cost-effectiveness ratio and net monetary benefit of adopting the cleaning bundle over existing hospital cleaning practices.</p>
                </sec>
                <sec id="s0102">
                  <title>Results</title>
                  <p>Implementing the cleaning bundle cost $349 000 Australian dollars (AUD) and generated AUD$147 500 in cost savings. Infections prevented under the cleaning bundle returned a net monetary benefit of AUD$1.02 million and an incremental cost-effectiveness ratio of $4684 per QALY gained. There was an 86% chance that the bundle was cost-effective compared with existing hospital cleaning practices.</p>
                </sec>
                <sec id="s0103">
                  <title>Conclusions</title>
                  <p>A bundled, evidence-based approach to improving hospital cleaning is a cost-effective intervention for reducing the incidence of HAIs.</p>
                </sec>
              </abstract>
              <abstract abstract-type="teaser">
                <p>We evaluated the cost-effectiveness of an environmental cleaning bundle for preventing healthcare-associated infections. Compared with current hospital cleaning practices, bundle implementation was cost-effective at $4684 per quality-adjusted life-years based on predicted reductions in <italic>Staphylococcus aureus</italic> bacteremia and vancomycin-resistant infection rates.</p>
              </abstract>
              <kwd-group>
                <kwd>cost-effectiveness</kwd>
                <kwd>infection control</kwd>
                <kwd>healthcare-associated infections</kwd>
                <kwd>environmental cleaning</kwd>
                <kwd>hospital</kwd>
              </kwd-group>
              <funding-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>NHMRC</institution>
                      <institution-id institution-id-type="DOI">10.13039/501100000925</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>GNT1076006</award-id>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>Avondale College of Higher Education</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>Australian Catholic University</institution>
                      <institution-id institution-id-type="DOI">10.13039/501100000990</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>The University of Western Australia</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <counts>
                <page-count count="8"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <p>Infection-control programs deliver evidence-based strategies aimed at preventing healthcare-associated infections (HAIs) [<xref rid="CIT0001" ref-type="bibr">1</xref>]. Improving hand hygiene compliance [<xref rid="CIT0002" ref-type="bibr">2</xref>], healthcare worker education [<xref rid="CIT0003" ref-type="bibr">3</xref>], and optimal clinical practice bundles [<xref rid="CIT0004" ref-type="bibr">4</xref>] has been effective in reducing HAI burden, resulting in cost savings for health services and health benefits for patients [<xref rid="CIT0005" ref-type="bibr">5</xref>]. Nonetheless, HAIs remain a significant patient safety issue, with point prevalence estimates being approximately 5% in high-income countries [<xref rid="CIT0006" ref-type="bibr">6</xref>, <xref rid="CIT0007" ref-type="bibr">7</xref>].</p>
            <p>Environmental cleaning is an important element of an infection-control program [<xref rid="CIT0008" ref-type="bibr">8</xref>]. Pathogens responsible for HAIs survive on surfaces for many months [<xref rid="CIT0009" ref-type="bibr">9</xref>], increasing the risk of patient acquisition [<xref rid="CIT0010" ref-type="bibr">10</xref>]. To date, evaluations of environmental cleaning have been limited to the management of outbreaks or quasi-experimental studies [<xref rid="CIT0011" ref-type="bibr">11</xref>]. However, growing evidence supporting the link between environmental contamination and pathogen transmission [<xref rid="CIT0012" ref-type="bibr">12</xref>] has motivated research into the impact of improving routine cleaning practices on HAI rates [<xref rid="CIT0013" ref-type="bibr">13</xref>].</p>
            <p>In 2016–2017, the Researching Effective Approaches to Cleaning in Hospitals (REACH) study evaluated an environmental cleaning bundle for reducing HAI rates in 11 Australian hospitals [<xref rid="CIT0014" ref-type="bibr">14</xref>]. The bundle implemented 5 interventions targeted at improving cleaning practices, which emphasized engagement with environmental services staff. Bundle effectiveness was measured by improvements in frequent touch-point cleaning and rate reductions in <italic>Clostridium difficile</italic> infection (CDI), <italic>Staphylococcus aureus</italic> bacteremia (SAB), and vancomycin-resistant enterococci (VRE) infection.</p>
            <p>Investment in new infection-control initiatives redirects scarce resources from competing programs [<xref rid="CIT0015" ref-type="bibr">15</xref>]. The economic returns of new programs should ideally exceed those for programs that are displaced, and cost-effectiveness analysis is useful for deciding which programs should be supported. In this paper, we evaluate the cost-effectiveness of the REACH cleaning bundle. Our analysis considered the costs of implementing the bundle, expected cost savings from fewer infections, and changes to health outcomes. The results are intended to inform hospital decision makers about whether to adopt the cleaning bundle as part of a hospitalwide infection-control program. Methods and outcomes are reported in accordance with the Consolidated Health Economic Reporting Standards (CHEERS) statement (<xref ref-type="supplementary-material" rid="sup1">Supplementary File 1</xref>).</p>
            <sec sec-type="materials" id="s1">
              <title>METHODS</title>
              <sec id="s2">
                <title>Setting and Study Design</title>
                <p>Eleven hospitals participated in the REACH study, representing over 1700 environmental services staff and 6100 overnight beds in large public and private hospitals. All hospitals had an established HAI surveillance program in place before enrollment, which included data collection on healthcare-associated CDI, SAB, and VRE infections [<xref rid="CIT0014" ref-type="bibr">14</xref>, <xref rid="CIT0016" ref-type="bibr">16</xref>].</p>
                <p>The intervention was an environmental cleaning bundle with 5 evidence-based components targeting audit, communication, technique, training, and product [<xref rid="CIT0014" ref-type="bibr">14</xref>]. A full description of each bundle component is provided in <xref ref-type="supplementary-material" rid="sup1">Supplementary File 2</xref>. The bundle was implemented in all hospitals using a stepped-wedge cluster-randomized design, with intervention timings randomized after all hospitals were enrolled. Before switching to the intervention, hospitals completed a 4-week establishment and an 8-week control period. The length of the intervention varied between 20 and 50 weeks, with an average length of 35 weeks. The design allowed all hospitals to receive the intervention, with each acting as its own control. The sequential roll-out of the bundle maximized the feasibility and consistency of implementation across sites, allowing researchers to work with individual hospitals. Given baseline differences between hospitals in cleaning practices [<xref rid="CIT0017" ref-type="bibr">17</xref>], a pragmatic approach to implementation was taken, which allowed the bundle to be tailored to individual hospitals based on changes required to meet best-practice cleaning guidelines.</p>
                <p>Ethics approval for the REACH study was obtained locally from all participating hospitals, the Uniting Health Human Research Ethics Committee (approval number 1413), and the Queensland University of Technology Human Research Ethics Committee (approval number 1400000828).</p>
              </sec>
              <sec id="s3">
                <title>Analysis</title>
                <p>We evaluated the cost-effectiveness of the intervention over current hospital cleaning practices using data collected alongside the REACH study. Changes to costs reflected the healthcare system perspective and were defined as the cost of bundle implementation minus cost savings from modeled reductions in infection rates. Changes to health benefits were measured in quality-adjusted life-years (QALYs). Cost-effectiveness was evaluated over 62 weeks, from the start of the establishment period in the first hospital until the end of the study.</p>
                <p>Implementation costs covered the purchase of consumables and the value of staff time spent on bundle activities. Consumables were valued using unit costs and included promotional and training materials, audit equipment, and disinfectant for frequent touch-point cleaning. Staffing costs were based on time contributions from hospital management and environmental services staff and were valued using wage rates. Costs were valued in 2016 Australian dollars. No discounting was applied for time preferences given the short time horizon. Further details are in <xref ref-type="supplementary-material" rid="sup1">Supplementary File 3</xref>.</p>
                <p>Total implementation costs were organized by bundle component for preintervention (establishment/control) and intervention phases (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table 1</xref>). This allowed us to estimate the costs of establishing and maintaining the bundle and the relative contribution of different components. Expected per-hospital costs were calculated to inform on the implementation costs at a future site, accounting for differences in intervention length, occupied bed days, and numbers of environmental services staff employed.</p>
                <p>Bundle effectiveness was modeled using hospital surveillance data collected between May 2015 and July 2017 [<xref rid="CIT0016" ref-type="bibr">16</xref>]. Statistical models estimated the expected within-hospital change in infection rates per 10 000 occupied bed days from the intervention and were fitted separately to each infection. Models accounted for between-hospital differences in preintervention rates and included a linear time trend to capture pre-existing trends. Effectiveness was modeled by a binary step change, which started after the first 4 weeks of the intervention phase to account for an initial leaning period. For infections where the relative risk of the intervention was less than 1, model parameters were used to estimate the number of infections prevented under the intervention.</p>
                <p>Cost savings were measured by the value of bed days released and treatment costs avoided (<xref rid="T1" ref-type="table">Table 1</xref>). Excess length-of-stay estimates were sourced from studies identified by systematic reviews [<xref rid="CIT0018" ref-type="bibr">18</xref>, <xref rid="CIT0019" ref-type="bibr">19</xref>]. Where possible, we used separate estimates for the general ward and intensive care unit (ICU) and for different patient outcomes (died in hospital or discharged). The economic value of total bed days released was determined using 2 approaches representing different healthcare payer perspectives. The first approach was based on an Australian hospital chief executive officer’s (CEO’s) stated willingness to pay (WTP) for a bed day to reflect the perspective of the hospital decision maker [<xref rid="CIT0020" ref-type="bibr">20</xref>]. The second approach considered the accounting value of a hospital bed day based on historical spending. Accounting estimates were calculated using reported recurrent expenditure on admitted care and patient days in Australian public hospitals [<xref rid="CIT0021" ref-type="bibr">21</xref>, <xref rid="CIT0029" ref-type="bibr">29</xref>]. Dollar values were adjusted to 2016 Australian dollars to account for inflation in healthcare expenditure [<xref rid="CIT0022" ref-type="bibr">22</xref>]. Treatment costs covered diagnostic testing and antibiotics [<xref rid="CIT0023" ref-type="bibr">23</xref>, <xref rid="CIT0024" ref-type="bibr">24</xref>] following consultation with infectious disease experts. Vancomycin-resistant enterococci treatment costs were estimated by the weighted average of costs for treating bloodstream and urinary tract infections, as these accounted for 98% of reported preintervention infections.</p>
                <table-wrap id="T1" orientation="portrait" position="float">
                  <label>Table 1.</label>
                  <caption>
                    <p>Parameter Estimates and Prior Distributions for Evaluating the Cost-effectiveness of the Cleaning Bundle</p>
                  </caption>
                  <table frame="vsides" rules="groups">
                    <thead>
                      <tr>
                        <th rowspan="1" colspan="1">Parameter</th>
                        <th rowspan="1" colspan="1">Estimate</th>
                        <th rowspan="1" colspan="1">Prior Distribution</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1"><italic>Staphylococcus aureus</italic> bacteremia</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Log infection rate per 10 000 occupied bed days, pre-intervention</td>
                        <td rowspan="1" colspan="1">−0.03</td>
                        <td rowspan="1" colspan="1">Normal (−0.03,0.13)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Log relative risk, intervention</td>
                        <td rowspan="1" colspan="1">−0.20</td>
                        <td rowspan="1" colspan="1">Normal (−0.20, 0.16)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Excess length of stay from infection, days [<xref rid="CIT0025" ref-type="bibr">25</xref>]</td>
                        <td rowspan="1" colspan="1">12.7 (general ward, discharged)</td>
                        <td rowspan="1" colspan="1">Normal (12.7, 2.2)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">−1.5 (general ward, died)</td>
                        <td rowspan="1" colspan="1">Normal (−1.5, 3.3)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.9 (ICU, discharged)</td>
                        <td rowspan="1" colspan="1">Normal (0.9, 0.7)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">1.4 (ICU, died)</td>
                        <td rowspan="1" colspan="1">Normal (1.4, 0.6)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Treatment costs per infection [<xref rid="CIT0023" ref-type="bibr">23</xref>, <xref rid="CIT0024" ref-type="bibr">24</xref>]</td>
                        <td rowspan="1" colspan="1">$1017</td>
                        <td rowspan="1" colspan="1">Fixed</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Probability of death [<xref rid="CIT0025" ref-type="bibr">25</xref>]</td>
                        <td rowspan="1" colspan="1">0.06 (not infected)</td>
                        <td rowspan="1" colspan="1">Beta (175, 2775)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.17 (infected)</td>
                        <td rowspan="1" colspan="1">Beta (124, 620)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Average patient age [<xref rid="CIT0026" ref-type="bibr">26</xref>], years</td>
                        <td rowspan="1" colspan="1">62</td>
                        <td rowspan="1" colspan="1">Fixed</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Life expectancy at time of infection, years [<xref rid="CIT0027" ref-type="bibr">27</xref>]</td>
                        <td rowspan="1" colspan="1">25.0 (female); 22.1 (male)</td>
                        <td rowspan="1" colspan="1">Fixed</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">VRE infection</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Log infection rate per 10 000 occupied bed days, preintervention</td>
                        <td rowspan="1" colspan="1">−1.0</td>
                        <td rowspan="1" colspan="1">Normal (−1.0, 0.46)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Log relative risk, intervention</td>
                        <td rowspan="1" colspan="1">−0.46</td>
                        <td rowspan="1" colspan="1">Normal (−0.46, 0.14)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Excess length of stay from infection, days [<xref rid="CIT0018" ref-type="bibr">18</xref>]</td>
                        <td rowspan="1" colspan="1">3.8</td>
                        <td rowspan="1" colspan="1">Uniform (3.0, 4.6)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Mortality risk [<xref rid="CIT0028" ref-type="bibr">28</xref>]</td>
                        <td rowspan="1" colspan="1">0.07 (not infected)</td>
                        <td rowspan="1" colspan="1">Beta (35, 497)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.10 (infected)</td>
                        <td rowspan="1" colspan="1">Beta (52, 480)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Treatment costs per infection [<xref rid="CIT0023" ref-type="bibr">23</xref>]</td>
                        <td rowspan="1" colspan="1">$1708 (BSI); $844 (UTI)</td>
                        <td rowspan="1" colspan="1">Fixed</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Log odds of VRE BSI vs VRE UTI<sup>a</sup></td>
                        <td rowspan="1" colspan="1">0.38</td>
                        <td rowspan="1" colspan="1">Normal (−0.49, 0.42)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Average patient age [<xref rid="CIT0028" ref-type="bibr">28</xref>], years</td>
                        <td rowspan="1" colspan="1">66</td>
                        <td rowspan="1" colspan="1">Fixed</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Life expectancy at time of infection, years [<xref rid="CIT0027" ref-type="bibr">27</xref>]</td>
                        <td rowspan="1" colspan="1">21.5 (female); 18.9 (male)</td>
                        <td rowspan="1" colspan="1">Fixed</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"><italic>Clostridium difficile</italic> infection</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Log infection rate per 10 000 occupied bed days, preintervention</td>
                        <td rowspan="1" colspan="1">0.85</td>
                        <td rowspan="1" colspan="1">Normal (0.85, 0.21)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Log relative risk, intervention<sup>b</sup></td>
                        <td rowspan="1" colspan="1">0.07</td>
                        <td rowspan="1" colspan="1">Normal (0.07, 0.10)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Health benefits</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Health utilities, Australian norms [<xref rid="CIT0029" ref-type="bibr">29</xref>]</td>
                        <td rowspan="1" colspan="1">0.80 (75+ years)</td>
                        <td rowspan="1" colspan="1">Beta (546,136)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">0.82 (65–74 years)</td>
                        <td rowspan="1" colspan="1">Beta (2066, 594)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Dollar value per bed day released</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Willingness to pay [<xref rid="CIT0020" ref-type="bibr">20</xref>, <xref rid="CIT0022" ref-type="bibr">22</xref>]</td>
                        <td rowspan="1" colspan="1">$284 (general ward)</td>
                        <td rowspan="1" colspan="1">Normal (284, 23)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">$573 (ICU)</td>
                        <td rowspan="1" colspan="1">Normal (573, 86)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Accounting cost [<xref rid="CIT0021" ref-type="bibr">21</xref>, <xref rid="CIT0030" ref-type="bibr">30</xref>]</td>
                        <td rowspan="1" colspan="1">$1667 (general ward); $6280 (ICU)</td>
                        <td rowspan="1" colspan="1">Fixed</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="fn-0100">
                      <p>Abbreviations: BSI, bloodstream infection; ICU, intensive care unit; REACH, Researching Effective Approaches to Cleaning in Hospitals; UTI, urinary tract infection; VRE, vancomycin-resistant enterococci.</p>
                    </fn>
                    <fn id="fn-0101">
                      <p><sup>a</sup>Determined from REACH study data.</p>
                    </fn>
                    <fn id="fn-0102">
                      <p><sup>b</sup>Insufficient evidence of bundle effectiveness to assign cost savings and health benefits.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Out of the number of infections prevented, we assumed that a proportion of patients would have died due to infection. Mortality risks were sourced from the same studies identified for extra length of stay if available (<xref rid="T1" ref-type="table">Table 1</xref>). Total years of life gained were calculated as the difference between the average age of infected patients and life expectancies at the time of infection [<xref rid="CIT0027" ref-type="bibr">27</xref>]. Years of life gained were converted to QALYs using age-group–specific health utilities measured in the Australian general population [<xref rid="CIT0029" ref-type="bibr">29</xref>]. Total QALYs were discounted by 3% per annum to reflect the reduced future value of health benefits [<xref rid="CIT0031" ref-type="bibr">31</xref>].</p>
                <p>The cost-effectiveness of the intervention was evaluated using the incremental cost-effectiveness ratio (ICER) and net monetary benefit (NMB), which offered different summaries of the change in costs versus health benefits. The ICER reports the incremental cost per QALY gained, which is compared with a maximum WTP per QALY:</p>
                <disp-formula>
                  <mml:math id="m1">
                    <mml:mstyle displaystyle="true">
                      <mml:mtable columnalign="left" columnspacing="1">
                        <mml:mtr>
                          <mml:mtd>
                            <mml:mstyle displaystyle="true">
                              <mml:mi mathvariant="normal">I</mml:mi>
                              <mml:mi mathvariant="normal">C</mml:mi>
                              <mml:mi mathvariant="normal">E</mml:mi>
                              <mml:mi mathvariant="normal">R</mml:mi>
                              <mml:mo>=</mml:mo>
                              <mml:mrow>
                                <mml:mtext> </mml:mtext>
                              </mml:mrow>
                              <mml:mrow>
                                <mml:mtext> </mml:mtext>
                              </mml:mrow>
                              <mml:mfrac>
                                <mml:mrow>
                                  <mml:mi mathvariant="normal">C</mml:mi>
                                  <mml:mi mathvariant="normal">h</mml:mi>
                                  <mml:mi mathvariant="normal">a</mml:mi>
                                  <mml:mi mathvariant="normal">n</mml:mi>
                                  <mml:mi mathvariant="normal">g</mml:mi>
                                  <mml:mi mathvariant="normal">e</mml:mi>
                                  <mml:mrow>
                                    <mml:mtext> </mml:mtext>
                                  </mml:mrow>
                                  <mml:mrow>
                                    <mml:mtext> </mml:mtext>
                                  </mml:mrow>
                                  <mml:mi mathvariant="normal">i</mml:mi>
                                  <mml:mi mathvariant="normal">n</mml:mi>
                                  <mml:mrow>
                                    <mml:mtext> </mml:mtext>
                                  </mml:mrow>
                                  <mml:mrow>
                                    <mml:mtext> </mml:mtext>
                                  </mml:mrow>
                                  <mml:mi mathvariant="normal">c</mml:mi>
                                  <mml:mi mathvariant="normal">o</mml:mi>
                                  <mml:mi mathvariant="normal">s</mml:mi>
                                  <mml:mi mathvariant="normal">t</mml:mi>
                                  <mml:mi mathvariant="normal">s</mml:mi>
                                </mml:mrow>
                                <mml:mrow>
                                  <mml:mi mathvariant="normal">C</mml:mi>
                                  <mml:mi mathvariant="normal">h</mml:mi>
                                  <mml:mi mathvariant="normal">a</mml:mi>
                                  <mml:mi mathvariant="normal">n</mml:mi>
                                  <mml:mi mathvariant="normal">g</mml:mi>
                                  <mml:mi mathvariant="normal">e</mml:mi>
                                  <mml:mrow>
                                    <mml:mtext> </mml:mtext>
                                  </mml:mrow>
                                  <mml:mrow>
                                    <mml:mtext> </mml:mtext>
                                  </mml:mrow>
                                  <mml:mi mathvariant="normal">i</mml:mi>
                                  <mml:mi mathvariant="normal">n</mml:mi>
                                  <mml:mrow>
                                    <mml:mtext> </mml:mtext>
                                  </mml:mrow>
                                  <mml:mrow>
                                    <mml:mtext> </mml:mtext>
                                  </mml:mrow>
                                  <mml:mi mathvariant="normal">Q</mml:mi>
                                  <mml:mi mathvariant="normal">A</mml:mi>
                                  <mml:mi mathvariant="normal">L</mml:mi>
                                  <mml:mi mathvariant="normal">Y</mml:mi>
                                  <mml:mi mathvariant="normal">s</mml:mi>
                                </mml:mrow>
                              </mml:mfrac>
                            </mml:mstyle>
                          </mml:mtd>
                        </mml:mtr>
                      </mml:mtable>
                    </mml:mstyle>
                  </mml:math>
                </disp-formula>
                <p>In contrast, NMB is a rearrangement of the ICER that summarizes the difference between the economic value of health benefits and the change in costs:</p>
                <disp-formula>
                  <mml:math id="m2">
                    <mml:mstyle displaystyle="true">
                      <mml:mtable columnalign="left" columnspacing="1">
                        <mml:mtr>
                          <mml:mtd>
                            <mml:mstyle displaystyle="true">
                              <mml:mi mathvariant="normal">N</mml:mi>
                              <mml:mi mathvariant="normal">M</mml:mi>
                              <mml:mi mathvariant="normal">B</mml:mi>
                              <mml:mo>=</mml:mo>
                              <mml:mrow>
                                <mml:mo>(</mml:mo>
                                <mml:mi mathvariant="normal">W</mml:mi>
                                <mml:mi mathvariant="normal">T</mml:mi>
                                <mml:mi mathvariant="normal">P</mml:mi>
                                <mml:mo>×</mml:mo>
                                <mml:mi mathvariant="normal">C</mml:mi>
                                <mml:mi mathvariant="normal">h</mml:mi>
                                <mml:mi mathvariant="normal">a</mml:mi>
                                <mml:mi mathvariant="normal">n</mml:mi>
                                <mml:mi mathvariant="normal">g</mml:mi>
                                <mml:mi mathvariant="normal">e</mml:mi>
                                <mml:mrow>
                                  <mml:mtext> </mml:mtext>
                                </mml:mrow>
                                <mml:mrow>
                                  <mml:mtext> </mml:mtext>
                                </mml:mrow>
                                <mml:mi mathvariant="normal">i</mml:mi>
                                <mml:mi mathvariant="normal">n</mml:mi>
                                <mml:mrow>
                                  <mml:mtext> </mml:mtext>
                                </mml:mrow>
                                <mml:mrow>
                                  <mml:mtext> </mml:mtext>
                                </mml:mrow>
                                <mml:mi mathvariant="normal">Q</mml:mi>
                                <mml:mi mathvariant="normal">A</mml:mi>
                                <mml:mi mathvariant="normal">L</mml:mi>
                                <mml:mi mathvariant="normal">Y</mml:mi>
                                <mml:mi mathvariant="normal">s</mml:mi>
                                <mml:mo>)</mml:mo>
                              </mml:mrow>
                              <mml:mo>−</mml:mo>
                              <mml:mi mathvariant="normal">C</mml:mi>
                              <mml:mi mathvariant="normal">h</mml:mi>
                              <mml:mi mathvariant="normal">a</mml:mi>
                              <mml:mi mathvariant="normal">n</mml:mi>
                              <mml:mi mathvariant="normal">g</mml:mi>
                              <mml:mi mathvariant="normal">e</mml:mi>
                              <mml:mrow>
                                <mml:mtext> </mml:mtext>
                              </mml:mrow>
                              <mml:mrow>
                                <mml:mtext> </mml:mtext>
                              </mml:mrow>
                              <mml:mi mathvariant="normal">i</mml:mi>
                              <mml:mi mathvariant="normal">n</mml:mi>
                              <mml:mrow>
                                <mml:mtext> </mml:mtext>
                              </mml:mrow>
                              <mml:mrow>
                                <mml:mtext> </mml:mtext>
                              </mml:mrow>
                              <mml:mi mathvariant="normal">c</mml:mi>
                              <mml:mi mathvariant="normal">o</mml:mi>
                              <mml:mi mathvariant="normal">s</mml:mi>
                              <mml:mi mathvariant="normal">t</mml:mi>
                              <mml:mi mathvariant="normal">s</mml:mi>
                            </mml:mstyle>
                          </mml:mtd>
                        </mml:mtr>
                      </mml:mtable>
                    </mml:mstyle>
                  </mml:math>
                </disp-formula>
                <p>Interventions with a positive NMB or an ICER less than the chosen WTP threshold are cost-effective. Our analysis used a WTP threshold of $28 000/QALY, which reflected the opportunity cost of additional healthcare expenditures under a constrained budget [<xref rid="CIT0032" ref-type="bibr">32</xref>].</p>
                <p>Probabilistic sensitivity analysis was undertaken to account for uncertainty in model parameters and its impact on cost-effectiveness outcomes. Selected prior distributions characterized uncertainty in bundle effectiveness, literature-based parameters, and hospital costs (<xref rid="T1" ref-type="table">Table 1</xref>). Uncertainty in staff time costs was modeled using uniform distributions by staff role, defined by minimum and maximum hourly rates. Uniform distributions were also used to add a 10% margin of error to weekly incremental costs for disinfectant to reflect the likelihood that hospitalwide changes in product use were not exclusively driven by recommended changes in frequent touch-point cleaning. Outcomes from sensitivity analyses were based on 10 000 simulations. Given issues with interpreting uncertainty in the ICER [<xref rid="CIT0033" ref-type="bibr">33</xref>], the probability that the intervention was cost-effective was calculated as the proportion of model simulations that returned a positive NMB.</p>
              </sec>
            </sec>
            <sec id="s4">
              <title>RESULTS</title>
              <sec id="s5">
                <title>REACH Bundle Effectiveness</title>
                <p>The intervention was associated with a decrease in SAB and VRE infection rates, with a combined 40 infections prevented over approximately 1.3 million occupied bed days. Bundle effectiveness estimates were larger for SAB (23.5 infections prevented; 95% confidence interval [CI], −15.3 to 62.0) compared with VRE (16.0 infections prevented; 95% CI, 0.1–32.1); however, the former had greater statistical uncertainty. Insufficient evidence of effectiveness on CDI rates (relative risk, 1.07; 95% CI, 0.88–1.30) led to its exclusion from subsequent analysis, given our focus on cost savings and health benefits from fewer infections. Infections prevented under the intervention resulted in a combined gain of 43 QALYs (95% CI, −17.8 to 160.5).</p>
              </sec>
              <sec id="s6">
                <title>Cost Outcomes</title>
                <p>Implementing the cleaning bundle cost approximately $349 000 (95% CI, $331 000–$367 000), or $2430 per 10 000 occupied bed days during the intervention phase (<xref ref-type="fig" rid="F1">Figure 1</xref>). Changing disinfectant represented 34% of total costs ($118 000; 95% CI, $107 000–$129 000) or $823 per 10 000 occupied bed days. Preintervention audit activities and study-related implementation incurred similar costs; however, their overall contribution was relatively small, consuming 15% of total costs. After accounting for differences in occupied bed days, the expected per-hospital costs of establishing and maintaining the cleaning bundle were approximately $4960 (95% CI, $4700–$5200) and $29 400 (95% CI, $27 700–$31 000), respectively. Hospital-level disinfectant costs were a key source of heterogeneity between hospitals, ranging from $838 saved to an additional $3090 spent per 10 000 intervention-occupied bed days. A further breakdown of costs is provided in <xref ref-type="supplementary-material" rid="sup1">Supplementary Tables 2 and 3</xref>.</p>
                <fig id="F1" orientation="portrait" position="float">
                  <label>Figure 1. </label>
                  <caption>
                    <p>Summary of total trial costs across all hospitals by phase and bundle component. Estimates are expected values from 10 000 model simulations. Gray = preintervention; black = intervention. Abbreviation: AUD, Australian dollars.</p>
                  </caption>
                  <graphic xlink:href="ciz717f0001"/>
                </fig>
                <p>Fewer infections during the intervention phase released 346 bed days and generated $147 000 in savings under the CEO WTP approach to valuing bed days (<xref rid="T2" ref-type="table">Table 2</xref>). Approximately one-third of savings were from treatments avoided, with cost savings marginally higher for SAB ($23 900; 95% CI, −$16 000 to $63 000) compared with VRE ($18 800; 95% CI, $125–$38 000). Total savings based on accounting values were higher, resulting in a net cost saving of $375 000 (95% CI, -$1 486 000 to $605 000). Because extra length-of-stay estimates for VRE were not available separately for the general ward and the ICU, our analysis assumed cost savings for this infection based on general ward values only. A follow-up analysis of this assumption and its impact on expected cost savings is provided in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table 4</xref>.</p>
                <table-wrap id="T2" orientation="portrait" position="float">
                  <label>Table 2.</label>
                  <caption>
                    <p>Estimated Cost Savings From Fewer <italic>Staphylococcus aureus</italic> bacteremia and vancomycin-resistant enterococci Infections</p>
                  </caption>
                  <table frame="vsides" rules="groups">
                    <thead>
                      <tr>
                        <th rowspan="1" colspan="1"/>
                        <th colspan="2" rowspan="1">Estimate (95% CI)</th>
                      </tr>
                      <tr>
                        <th rowspan="1" colspan="1">Outcome</th>
                        <th rowspan="1" colspan="1">SAB</th>
                        <th rowspan="1" colspan="1">VRE</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">Bed days released</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> General Ward</td>
                        <td rowspan="1" colspan="1">263 (−162 to 751)</td>
                        <td rowspan="1" colspan="1">61 (−.1 to 127)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> ICU</td>
                        <td rowspan="1" colspan="1">22 (−18 to 89)</td>
                        <td rowspan="1" colspan="1">…</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Dollar value of bed days released</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Accounting</td>
                        <td rowspan="1" colspan="1">$579 507 (−$346 131 to $1 647 934)</td>
                        <td rowspan="1" colspan="1">$101 404 ($652 to $210 925)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> CEO WTP</td>
                        <td rowspan="1" colspan="1">$87 547 (−$54 856 to $246 323)</td>
                        <td rowspan="1" colspan="1">$17 272 ($110 to $36 498)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Treatment costs avoided</td>
                        <td rowspan="1" colspan="1">$23 884 (−$15 537 to $63 109)</td>
                        <td rowspan="1" colspan="1">$18 814 ($125 to $38 255)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Accounting</td>
                        <td rowspan="1" colspan="1">$25 721 ($15 481 to $36 082)</td>
                        <td rowspan="1" colspan="1">$7508 ($6226 to $8795)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> CEO WTP</td>
                        <td rowspan="1" colspan="1">$4749 ($3342 to $6249)</td>
                        <td rowspan="1" colspan="1">$2254 ($1927 to $2603)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Change in total costs</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Accounting</td>
                        <td rowspan="1" colspan="1">−$374 708 (−$1 485 578 to $605 129)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> CEO WTP</td>
                        <td rowspan="1" colspan="1">$201 398 ($4507 to $385 570)</td>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="fn-0103">
                      <p>Abbreviations: CI, confidence interval; ICU, intensive care unit; CEO, chief executive officer; SAB, <italic>Staphylococcus aureus</italic> bacteremia; VRE, vancomycin-resistant enterococci; WTP, willingness to pay.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>There was strong evidence that the intervention was cost-effective; however, outcomes were affected by the approach taken for valuing bed days (<xref ref-type="fig" rid="F2">Figure 2</xref>). Under the conservative CEO WTP approach, the NMB of the cleaning bundle was approximately $1.02 million, with an expected ICER of $4684 per QALY. In contrast, higher dollar values assigned to general ward and ICU bed days under the accounting approach returned a NMB of $1.6 million and an expected savings of $8685 per QALY. Despite these differences, the probability that the intervention was cost-effective was consistently high, with 86% and 88% of model simulations returning a positive NMB under CEO WTP and accounting approaches, respectively.</p>
                <fig id="F2" orientation="portrait" position="float">
                  <label>Figure 2. </label>
                  <caption>
                    <p>Cost-effectiveness plane (<italic>top panel</italic>). Distribution of NMB (<italic>bottom panel</italic>). Outcomes are colored according to the approach for valuing hospital bed days (gray = accounting; black = CEO willingness to pay). Abbreviations: AUD, Australian dollars; CEO, chief executive officer; NMB, net monetary benefit; Pr, probability; QALY, quality-adjusted life-year.</p>
                  </caption>
                  <graphic xlink:href="ciz717f0002"/>
                </fig>
              </sec>
            </sec>
            <sec id="s7">
              <title>DISCUSSION</title>
              <p>Our study has shown that the REACH cleaning bundle is likely to be a cost-effective intervention for reducing HAI burden. Using data collected from a representative mix of Australian hospitals, adopting the bundle cost $4684 per QALY and had greater than an 80% chance of being cost-effective. Pragmatic implementation of the bundle in real-world hospital settings combined with prospective data collection under a stepped-wedge design produced high-quality evidence that the bundle would be cost-effective if implemented elsewhere in similar hospitals for reducing healthcare-associated SAB and VRE infections.</p>
              <p>Differences between approaches to valuing bed days highlighted the importance of healthcare payer perspective and its impact on decision making. While cost-effectiveness probabilities were robust, the use of accounting values predicted net cost savings from fewer SAB and VRE infections. Unlike resources such as antibiotics that incur direct expenditure, bed days are an opportunity cost of treating an HAI [<xref rid="CIT0034" ref-type="bibr">34</xref>], and their release for use by other patients does not result in immediate cash savings [<xref rid="CIT0015" ref-type="bibr">15</xref>]. As the outcomes of cost-effectiveness analysis are intended to inform decisions about the reallocation of scarce resources, the WTP approach is recommended to avoid overstating expected savings from proposed interventions.</p>
              <p>Insufficient evidence of the bundle in reducing CDI rates led to its exclusion from analysis. We have no plausible reason to believe that the intervention increased CDI rates, as it was implemented alongside ongoing infection-control activities. A possible explanation for this result is the impact of CDI reservoirs in the community and subsequent transmission of genetically diverse strains into the hospital setting [<xref rid="CIT0035" ref-type="bibr">35</xref>]. Furthermore, not all hospitals used a sporicidal disinfectant [<xref rid="CIT0017" ref-type="bibr">17</xref>] and, because the bundle did not prescribe specific cleaning products, it is likely that some products used were ineffective against CDI.</p>
              <p>Costing information sought to inform on real-world implementation costs but was subject to limitations. Low-quality data on detergent use led to their exclusion from analysis; however, the effect of this was likely to be small as practice changes predominantly involved increased disinfectant use for frequent touch-point cleaning. Furthermore, costs were not attributed to improving cleaning technique as this would have required time-in-motion studies. Instead, we assumed that the number of cleaning staff within a hospital did not change, and that staff would be cleaning more effectively due to improved product use and cleaning technique. No major changes to staffing were reported as part of routine monitoring throughout the study.</p>
              <p>Cost savings relied on secondary data sources for extra length of stay and infection-related mortality. Outcomes from multistate modeling studies were used for SAB to minimize the risk of time-dependent bias [<xref rid="CIT0019" ref-type="bibr">19</xref>, <xref rid="CIT0036" ref-type="bibr">36</xref>, <xref rid="CIT0037" ref-type="bibr">37</xref>]; however, similar studies for VRE infection were unavailable. Vancomycin-resistant enterococci estimates were sourced from studies with comparable patient infection case mix and were comparable with other HAI studies [<xref rid="CIT0038" ref-type="bibr">38</xref>, <xref rid="CIT0039" ref-type="bibr">39</xref>]. Future studies of VRE outcomes should prioritize the use of multistate modeling to address this limitation and the differential effects of bloodstream versus urinary tract infection.</p>
              <p>Treatment costs per infection were based on expert opinion and are a potential limitation of our model. However, resulting cost savings were conservative compared with other studies. For example, a retrospective cohort analysis on the costs of SAB-related hospitalizations between 2010 and 2014 reported estimates of US$15 578–$40 725 for methicillin-susceptible Staphylococcus aureus and US$14 792–$34 526 for methicillin-resistant S. aureus [<xref rid="CIT0040" ref-type="bibr">40</xref>]. Attributable costs per VRE infection of US$6565–$14 850 have also been published [<xref rid="CIT0041" ref-type="bibr">41</xref>, <xref rid="CIT0042" ref-type="bibr">42</xref>].</p>
              <p>It is possible that a Hawthorne effect contributed to bundle effectiveness outcomes, as hospital staff were likely to change behavior because they were being monitored. Given the inclusion of monthly audits as a fixed element of the bundle, such an effect can be considered as part of the bundle as staff were likely to change their behavior precisely because they were being monitored.</p>
              <p>Findings from this study compare favorably against other HAI prevention strategies and provide evidence for allocating hospital resources to improving cleaning. In the United States, a 10-year study of investment in infection-prevention measures produced an ICER of US$23 278 (AUD$31 457; 1 AUD = 0.74 USD) per QALY based on reductions in central line–associated bloodstream infections and ventilator-associated pneumonia [<xref rid="CIT0005" ref-type="bibr">5</xref>]. A retrospective evaluation of the Australian National Hand Hygiene Initiative reported similar outcomes for SAB, with an incremental program cost of AUD$29 700 per QALY [<xref rid="CIT0026" ref-type="bibr">26</xref>]. While this comparison raises questions about disinvestment from more expensive prevention strategies, we stress that our analysis describes the incremental cost-effectiveness of improved cleaning conditional on existing measures. Decision makers should therefore consider these results in the context of current hospital practices and the relative effectiveness of current infection-control measures.</p>
            </sec>
            <sec sec-type="supplementary-material" id="s8">
              <title>Supplementary Data</title>
              <p>Supplementary materials are available at <italic>Clinical Infectious Diseases</italic> online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.</p>
              <supplementary-material content-type="local-data" id="sup1">
                <label>ciz717_Suppl_Supplementary_Material</label>
                <media xlink:href="ciz717_suppl_supplementary_material.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <notes id="n1">
              <title>Notes</title>
              <p><bold><italic>Acknowledgments.</italic></bold> The authors thank the staff of the 11 study hospitals and the REACH study team members: Michelle Allen, Carla Shield, and Alexandra McGhie. They also thank the 2 reviewers for their time and valuable feedback on the original submission.</p>
              <p><bold><italic>Disclaimer.</italic></bold> The contents of the published material are solely the responsibility of the administering institution, participating institutions, and the individual authors; they do not reflect the views of the National Health and Medical Research Council (NHMRC).</p>
              <p><bold><italic>Financial support.</italic></bold> The REACH study was an NHMRC-funded 2014–2017 Partnership Project (GNT1076006), led by Queensland University of Technology in conjunction with Wesley Medical Research. Academic project partners at Avondale College of Higher Education, Australian Catholic University, and The University of Western Australia provided in-kind contributions to the study design, conduct, data analysis and interpretation, and the publication and dissemination of results. Industry partners Kimberly-Clark Professional, Ecolab Pty Ltd, and Whiteley Corporation provided financial and equipment resources to support data collection but had no role in the study design, implementation, or analysis.</p>
              <p><bold><italic>Potential conflicts of interest.</italic></bold> All authors report grants from the NHMRC during the conduct of this study. All authors report nonfinancial support from Kimberly-Clark Professional, Ecolab Pty Ltd, and Whiteley Corporation during the conduct of this study. C. A. G. reports grants from the Wesley Research Institute and partner organizations during the conduct of this study. D. L. P. reports grants from Shionogi and Merck (MSD) and personal fees from Merck, Pfizer, Shionogi, Achaogen, AstraZeneca, Leo Pharmaceuticals, Bayer, GlaxoSmithKline, Cubist, Venatorx, and Accelerate outside the submitted work. T. V. R. reports grants and nonfinancial support from GAMA Health, Roche Molecular Systems, Summit Pharmaceuticals, Merck, Sanofi, and Cepheid outside the submitted work. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.</p>
            </notes>
            <ref-list id="r1">
              <title>References</title>
              <ref id="CIT0001">
                <label>1.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zingg</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Holmes</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dettenkofer</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>; <person-group><collab>Systematic Review and Evidence-based Guidance on Organization of Hospital Infection Control Programmes (SIGHT) Study Group</collab></person-group><article-title>Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus</article-title>. <source>Lancet Infect Dis</source><year>2015</year>; <volume>15</volume>:<fpage>212</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">25467650</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0002">
                <label>2.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pittet</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hugonnet</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Harbarth</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group><article-title>Effectiveness of a hospital-wide programme to improve compliance with hand hygiene: Infection Control Programme</article-title>. <source>Lancet</source><year>2000</year>; <volume>356</volume>:<fpage>1307</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">11073019</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0003">
                <label>3.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eckstein</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Eckstein</surname><given-names>EC</given-names></name>, <etal>et al.</etal></person-group><article-title>Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods</article-title>. <source>BMC Infect Dis</source><year>2007</year>; <volume>7</volume>:<fpage>61</fpage>.<pub-id pub-id-type="pmid">17584935</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0004">
                <label>4.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burden</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Torjman</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Dy</surname><given-names>GE</given-names></name>, <etal>et al.</etal></person-group><article-title>Prevention of central venous catheter-related bloodstream infections: is it time to add simulation training to the prevention bundle?</article-title><source>J Clin Anesth</source><year>2012</year>; <volume>24</volume>:<fpage>555</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">23101770</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0005">
                <label>5.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dick</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Perencevich</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Pogorzelska-Maziarz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zwanziger</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Larson</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Stone</surname><given-names>PW</given-names></name></person-group><article-title>A decade of investment in infection prevention: a cost-effectiveness analysis</article-title>. <source>Am J Infect Control</source><year>2015</year>; <volume>43</volume>:<fpage>4</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">25564117</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0006">
                <label>6.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zarb</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Coignard</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Griskeviciene</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Muller</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vankerckhoven</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Goossens</surname><given-names>H</given-names></name></person-group><article-title>The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use</article-title>. <source>Euro Surveill</source><year>2012</year>; <volume>17</volume>: <fpage>20316</fpage>.<pub-id pub-id-type="pmid">23171822</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0007">
                <label>7.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magill</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Bamberg</surname><given-names>W</given-names></name>, <etal>et al</etal></person-group>; <person-group><collab>Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team</collab></person-group><article-title>Multistate point-prevalence survey of health care-associated infections</article-title>. <source>N Engl J Med</source><year>2014</year>; <volume>370</volume>:<fpage>1198</fpage>–<lpage>208</lpage>.<pub-id pub-id-type="pmid">24670166</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0008">
                <label>8.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donskey</surname><given-names>CJ</given-names></name></person-group><article-title>Does improving surface cleaning and disinfection reduce health care-associated infections?</article-title><source>Am J Infect Control</source><year>2013</year>; <volume>41</volume>:<fpage>S12</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">23465603</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0009">
                <label>9.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dancer</surname><given-names>SJ</given-names></name></person-group><article-title>Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination</article-title>. <source>Clin Microbiol Rev</source><year>2014</year>; <volume>27</volume>:<fpage>665</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">25278571</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0010">
                <label>10.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Dancer</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dehn</surname><given-names>E</given-names></name></person-group><article-title>Risk of organism acquisition from prior room occupants: a systematic review and meta-analysis</article-title>. <source>J Hosp Infect</source><year>2015</year>; <volume>91</volume>:<fpage>211</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">26365827</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0011">
                <label>11.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sullivan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Beas</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Pegues</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kaczmarek</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Umcheid</surname><given-names>C</given-names></name></person-group><article-title>Cleaning hospital room surfaces to prevent healthcare-associated infections: a technical brief</article-title>. <source>Ann Intern Med</source><year>2015</year>; <volume>163</volume>:<fpage>598</fpage>–<lpage>607</lpage>.<pub-id pub-id-type="pmid">26258903</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0012">
                <label>12.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyce</surname><given-names>JM</given-names></name></person-group><article-title>Environmental contamination makes an important contribution to hospital infection</article-title>. <source>J Hosp Infect</source><year>2007</year>; <volume>65</volume>(<issue>Suppl 2</issue>):<fpage>50</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">17540242</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0013">
                <label>13.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>LF</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>DJ</given-names></name>, <etal>et al</etal></person-group>; <person-group><collab>CDC Prevention Epicenters Program</collab></person-group><article-title>Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study</article-title>. <source>Lancet</source><year>2017</year>; <volume>389</volume>:<fpage>805</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">28104287</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0014">
                <label>14.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Farrington</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>BG</given-names></name>, <etal>et al.</etal></person-group><article-title>Researching effective approaches to cleaning in hospitals: protocol of the REACH study, a multi-site stepped-wedge randomised trial</article-title>. <source>Implement Sci</source><year>2016</year>; <volume>11</volume>:<fpage>44</fpage>.<pub-id pub-id-type="pmid">27009342</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0015">
                <label>15.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graves</surname><given-names>N</given-names></name></person-group><article-title>Economics and preventing hospital-acquired infection</article-title>. <source>Emerg Infect Dis</source><year>2004</year>; <volume>10</volume>:<fpage>561</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">15200842</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0016">
                <label>16.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>L</given-names></name>, <name name-style="western"><surname>White</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group><article-title>An environmental cleaning bundle to reduce healthcare-associated infection rates in hospitals: a randomized clinical trial</article-title>. <source>Lancet Infec Dis 2019; 19: 410-8</source>.</mixed-citation>
              </ref>
              <ref id="CIT0017">
                <label>17.</label>
                <mixed-citation publication-type="journal">Mitchell BG, Farrington A, Allen M, et al. Variation in hospital cleaning practice and process in Australian hospitals: a structured mapping exercise. Infect Dis Health 2017; 22:195–202.</mixed-citation>
              </ref>
              <ref id="CIT0018">
                <label>18.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiang</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Perencevich</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Nair</surname><given-names>R</given-names></name>, <etal>et al.</etal></person-group><article-title>Incidence and outcomes associated with infections caused by vancomycin-resistant enterococci in the United States: systematic literature review and meta-analysis</article-title>. <source>Infect Control Hosp Epidemiol</source><year>2017</year>; <volume>38</volume>:<fpage>203</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">27825401</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0019">
                <label>19.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manoukian</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dancer</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group><article-title>Estimating excess length of stay due to healthcare-associated infections: a systematic review and meta-analysis of statistical methodology</article-title>. <source>J Hosp Infect</source><year>2018</year>; <volume>100</volume>:<fpage>222</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">29902486</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0020">
                <label>20.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Page</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Barnett</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Graves</surname><given-names>N</given-names></name></person-group><article-title>What is a hospital bed day worth? A contingent valuation study of hospital chief executive officers</article-title>. <source>BMC Health Serv Res</source><year>2017</year>; <volume>17</volume>:<fpage>137</fpage>.<pub-id pub-id-type="pmid">28196489</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0021">
                <label>21.</label>
                <mixed-citation publication-type="book"><collab>Australian Institute of Health and Welfare</collab>. <source>Hospital resources 2015–16: Australian hospital statisti</source><source>cs</source>. Health services series no. 78. Cat. no. HSE 190. 
<publisher-loc>Canberra</publisher-loc>, Australia, <year>2017</year>.</mixed-citation>
              </ref>
              <ref id="CIT0022">
                <label>22.</label>
                <mixed-citation publication-type="book"><collab>Australian Bureau of Statistics</collab>. <source>Consumer Price Index, June 2018</source>. <publisher-loc>Canberra</publisher-loc>, Australia: 
<publisher-name>Commonwe</publisher-name><publisher-name>alth of Australia</publisher-name>, <year>2018</year>.</mixed-citation>
              </ref>
              <ref id="CIT0023">
                <label>23.</label>
                <mixed-citation publication-type="book"><collab>Australian Government, Department of Health</collab>. <source>Medicare Benefits Scheme</source>. Available at: <ext-link ext-link-type="uri" xlink:href="http://mbsonline.gov.au">mbsonline.gov.au</ext-link>. Accessed 21 December 2018.</mixed-citation>
              </ref>
              <ref id="CIT0024">
                <label>24.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wozniak</surname><given-names>TM</given-names></name></person-group><article-title>Clinical management of drug-resistant bacteria in Australian hospitals: an online survey of doctors’ opinions</article-title>. <source>Infect Dis Health</source><year>2018</year>; <volume>23</volume>:<fpage>41</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">30479303</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0025">
                <label>25.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnett</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Page</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group><article-title>The increased risks of death and extra lengths of hospital and ICU stay from hospital-acquired bloodstream infections: a case-control study</article-title>. <source>BMJ Open</source><year>2013</year>; <volume>3</volume>:<fpage>e003587</fpage>.</mixed-citation>
              </ref>
              <ref id="CIT0026">
                <label>26.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graves</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Page</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>E</given-names></name>, <etal>et al.</etal></person-group><article-title>Cost-effectiveness of a national initiative to improve hand hygiene compliance using the outcome of healthcare associated Staphylococcus aureus Bacteraemia</article-title>. <source>PLoS One</source><year>2016</year>; <volume>11</volume>:<fpage>e0148190</fpage>.<pub-id pub-id-type="pmid">26859688</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0027">
                <label>27.</label>
                <mixed-citation publication-type="book"><collab>Australian Bureau of Statistics</collab>. <source>Life tables, states, territories and Australia 2015–2017</source>. Cat. 3302.0.55.001. <year>Canberra, Australia: Commonwealth of Australia, 2018</year>.</mixed-citation>
              </ref>
              <ref id="CIT0028">
                <label>28.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayakawa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Marchaim</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Palla</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group><article-title>Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study</article-title>. <source>Antimicrob Agents Chemother</source><year>2013</year>; <volume>57</volume>:<fpage>49</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">23070173</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0029">
                <label>29.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clemens</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Begum</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Harper</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Whitty</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Scuffham</surname><given-names>PA</given-names></name></person-group><article-title>A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA</article-title>. <source>Qual Life Res</source><year>2014</year>; <volume>23</volume>:<fpage>2375</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">24676898</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0030">
                <label>30.</label>
                <mixed-citation publication-type="book"><collab>Australian Institute of Health and Welfare</collab>. <source>Admitted patient care 2015–16: Australian hospital statistics</source>. Health services series no.75. Cat. no. HSE 185. 
<publisher-loc>Canberra</publisher-loc>, Australia: Australian Institute of Health and Welfare (AIHW), <year>2017</year>.</mixed-citation>
              </ref>
              <ref id="CIT0031">
                <label>31.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitehead</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>S</given-names></name></person-group><article-title>Health outcomes in economic evaluation: the QALY and utilities</article-title>. <source>Br Med Bull</source><year>2010</year>; <volume>96</volume>:<fpage>5</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">21037243</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0032">
                <label>32.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edney</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Haji Ali Afzali</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Karnon</surname><given-names>J</given-names></name></person-group><article-title>Estimating the reference incremental cost-effectiveness ratio for the Australian Health System</article-title>. <source>Pharmacoeconomics</source><year>2018</year>; <volume>36</volume>:<fpage>239</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">29273843</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0033">
                <label>33.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stinnett</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Mullahy</surname><given-names>J</given-names></name></person-group><article-title>Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis</article-title>. <source>Med Decis Making</source><year>1998</year>; <volume>18</volume>:<fpage>S68</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">9566468</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0034">
                <label>34.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graves</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Harbarth</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Beyersmann</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Barnett</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Halton</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>B</given-names></name></person-group><article-title>Estimating the cost of health care-associated infections: mind your p’s and q’s</article-title>. <source>Clin Infect Dis</source><year>2010</year>; <volume>50</volume>:<fpage>1017</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">20178419</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0035">
                <label>35.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eyre</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Cule</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>DJ</given-names></name>, <etal>et al.</etal></person-group><article-title>Diverse sources of C. difficile infection identified on whole-genome sequencing</article-title>. <source>N Engl J Med</source><year>2013</year>; <volume>369</volume>:<fpage>1195</fpage>–<lpage>205</lpage>.<pub-id pub-id-type="pmid">24066741</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0036">
                <label>36.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nelson</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Khader</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group><article-title>The magnitude of time-dependent bias in the estimation of excess length of stay attributable to healthcare-associated infections</article-title>. <source>Infect Control Hosp Epidemiol</source><year>2015</year>; <volume>36</volume>:<fpage>1089</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">26041436</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0037">
                <label>37.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnett</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Beyersmann</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Allignol</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rosenthal</surname><given-names>VD</given-names></name>, <name name-style="western"><surname>Graves</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wolkewitz</surname><given-names>M</given-names></name></person-group><article-title>The time-dependent bias and its effect on extra length of stay due to nosocomial infection</article-title>. <source>Value Health</source><year>2011</year>; <volume>14</volume>:<fpage>381</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">21402305</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0038">
                <label>38.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Ferguson</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sear</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Barnett</surname><given-names>A</given-names></name></person-group><article-title>Length of stay and mortality associated with healthcare-associated urinary tract infections: a multi-state model</article-title>. <source>J Hosp Infect</source><year>2016</year>; <volume>93</volume>:<fpage>92</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">26944900</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0039">
                <label>39.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vrijens</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hulstaert</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Devriese</surname><given-names>S</given-names></name>, <name name-style="western"><surname>van de Sande</surname><given-names>S</given-names></name></person-group><article-title>Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs</article-title>. <source>Epidemiol Infect</source><year>2012</year>; <volume>140</volume>:<fpage>126</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="pmid">21320376</pub-id></mixed-citation>
              </ref>
              <ref id="CIT0040">
                <label>40.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klein</surname><given-names>EY</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Mojica</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group><article-title>National costs associated with methicillin-susceptible and methicillin-resistant Staphylococcus aureus hospitalizations in the United States, 2010–2014</article-title>. <source>Clin Infect Dis</source><year>2018</year>; <volume>68</volume>:<fpage>22</fpage>–<lpage>8</lpage>.</mixed-citation>
              </ref>
              <ref id="CIT0041">
                <label>41.</label>
                <mixed-citation publication-type="journal"><collab>Lloyd-Smith PJAjoic</collab>. <article-title>Controlling for endogeneity in attributable costs of vancomycin-resistant enterococci from a Canadian hospital</article-title>. <year>2017</year>; <volume>45</volume>:<fpage>e161</fpage>–<lpage>e4</lpage>.</mixed-citation>
              </ref>
              <ref id="CIT0042">
                <label>42.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puchter</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chaberny</surname><given-names>IF</given-names></name>, <name name-style="western"><surname>Schwab</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Vonberg</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Bange</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Ebadi</surname><given-names>E</given-names></name></person-group><article-title>Economic burden of nosocomial infections caused by vancomycin-resistant enterococci</article-title>. <source>Antimicrob Resist Infect Control</source><year>2018</year>; <volume>7</volume>:<fpage>1</fpage>.<pub-id pub-id-type="pmid">29312658</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
